Convergence Science
Convergence science combines the expertise of engineers, chemists, computer scientists, biologists, immunologists and medical doctors. Our team works together to transform the way we think of brain tumor therapy.
Learn moreAt The Brain Tumor Center at Siteman Cancer Center, WashU Medicine physicians are conducting pioneering research that is transforming the future of brain tumor treatment.
Watch VideoWith four signature research programs, The Brain Tumor Center at Siteman is at the forefront of innovation in neuro-oncology. Our researchers have developed therapies and technologies that are either currently under preclinical investigation or are being tested in unique, early-phase, investigator-initiated clinical trials.
Convergence science combines the expertise of engineers, chemists, computer scientists, biologists, immunologists and medical doctors. Our team works together to transform the way we think of brain tumor therapy.
Learn moreOur investigators hypothesize that epigenetic changes in the tumor and tumor environment cause treatment resistance and cancer recurrence. Re-defining glioblastoma tumors through this lens offers the exciting prospect of discovering new cancer cell vulnerabilities.
Learn moreCertain genetic alterations in the brain signal pathways that control growth, death and motility. Our team is developing novel targeted therapeutics by studying how these genetic changes drive brain tumor phenotypes.
Learn moreImmunotherapy uses vaccines, drugs and modified cells to activate the immune system to destroy tumors. Our experts are developing novel therapies that harness the immune system to specifically target brain tumors.
Learn moreCertain genetic alterations in the brain signal pathways that control growth, death and motility. Our team is developing novel targeted therapeutics by studying how these genetic changes drive brain tumor phenotypes.
Learn moreAlexander H. Stegh, PhD, is a leading brain cancer scientist. As the inaugural research director, Dr. Stegh has expanded the basic, translational and clinical research programs within The Brain Tumor Center while partnering with clinical and basic science departments at the School of Medicine.
Our investigators are examining new approaches to brain tumor treatment, including immunotherapies and targeted therapies.
Explore Our Clinical TrialsFrom the laboratory to the clinic to the hospital room, the multi-disciplinary team at The Brain Tumor Center works together to bring patients personalized, effective medicine.
Explore The Brain Tumor Center